NACFC 2020 | S24: Leveraging Lung Biology: Gateway to Therapy for All

Highly effective therapies for CFTR deficiency are available for 90% of CF patients. Unfortunately, the drugs will not help all patients and there is a pressing need to address therapeutic strategies that for all individuals with CF. This symposium will address innovative treatment strategies and features of airway biology we need to understand to bring effective therapy to all.